http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014074024-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67dd1f39f37bac4617e37d6d5c60aa8b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
filingDate 2013-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32aa552fbd521e664533449a7d6b2021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1930287d309ee04edb023cc5061d1074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45e342466659b178d31931588cc08577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cf7d34b443deede542c05c3831deb7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5af647c2220c0f6febecfe9d3f31c81d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c4cada7c745f36901c66be993fe0045
publicationDate 2014-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2014074024-A
titleOfInvention Pharmaceutical composition
abstract A nitrogen-containing saturated heterocyclic compound useful as a renin inhibitor is provided. A medicament comprising a compound of formula [I] or a pharmacologically acceptable salt thereof. [Wherein, R 1 is a cycloalkyl group or an unsubstituted alkyl group; R 22 is an optionally substituted aryl group, tetrahydronaphthyl group, naphthyridinyl group, pyridyl group, pyrazolopyridyl group, indolyl group, benzofuranyl group , Benzothienyl group, quinolyl group, chromanyl group, dihydrobenzofuranyl group, indazolyl group, etc .; R is a lower alkyl group or is bonded to R 22 at the end to form a ring; T is a carbonyl group Z is —O—, —NH— or a single bond; R 3 , R 4 , R 5 and R 6 are the same or different and each represents a hydrogen atom, an optionally substituted carbamoyl group or an optionally substituted; Good alkyl group. ] [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022048614-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019500385-A
priorityDate 2012-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011076786-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014042263-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012124775-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008153182-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466181131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68308656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59494811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414768582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467489987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163641307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420097548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68308668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68309091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146692659
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68308673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428015693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406888963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447473496
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465270949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428015696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467494763

Total number of triples: 48.